4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-005792
Options or other derivatives
- CHIEF COMMERCIAL OFFICER acquired 45,113 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-04-01 | Grant or award · Share Option | +38,668 | 38,668 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-04-01 | Grant or award · Restricted Share Unit | +6,445 | 6,445 | D | ||
Loading xslF345X04/form4-04032023_040423.xml…